Catherine M Cahill Selected Research

Weight Loss (Weight Reduction)

5/2022

Patterns of Use and Self-reported Effectiveness of Cannabis for Hyperemesis Gravidarum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catherine M Cahill Research Topics

Disease

30	Pain (Aches) 01/2024 - 02/2002
17	Chronic Pain 01/2024 - 09/2003
11	Neuralgia (Stump Neuralgia) 01/2022 - 02/2002
10	Hyperalgesia 01/2021 - 01/2003
9	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 08/2002
8	Parkinson Disease (Parkinson's Disease) 10/2020 - 11/2005
6	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 03/2016
5	Inflammation (Inflammations) 08/2019 - 01/2003
4	Neuroinflammatory Diseases 01/2024 - 01/2016
3	Substance-Related Disorders (Drug Abuse) 01/2024 - 10/2015
3	Hypersensitivity (Allergy) 11/2023 - 01/2014
3	Cognitive Dysfunction 01/2020 - 07/2009
3	Gliosis 01/2018 - 04/2010
2	Down Syndrome (Down's Syndrome) 09/2022 - 02/2019
2	Opiate Overdose 07/2021 - 11/2019
2	Lewy Body Disease (Lewy Body Dementia) 10/2020 - 01/2020
2	Dementia (Dementias) 01/2020 - 01/2012
2	Amyloidosis 01/2020 - 02/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 07/2009
2	Mood Disorders (Mood Disorder) 01/2019 - 01/2014
2	Neuroblastoma 01/2016 - 11/2002
2	Peripheral Nerve Injuries 01/2014 - 04/2010
2	Bipolar Disorder (Manic Depressive Psychosis) 10/2009 - 08/2009
1	Drug Misuse 01/2024
1	Brain Concussion (Cerebral Concussion) 11/2023
1	Weight Loss (Weight Reduction) 05/2022
1	Weight Gain 05/2022
1	Vomiting 05/2022
1	Nausea 05/2022
1	Acute Pain 01/2021
1	Multiple System Atrophy 10/2020
1	Alcoholism (Alcohol Abuse) 10/2020
1	Neurodevelopmental Disorders 10/2020
1	Respiratory Insufficiency (Respiratory Failure) 11/2019
1	Iron Overload 01/2019
1	Movement Disorders (Movement Disorder) 12/2018
1	Poisoning 01/2016
1	Necrotizing Enterocolitis 01/2016
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 05/2015

Drug/Important Bio-Agent (IBA)

24	Opioid Analgesics (Opioids)IBA 01/2024 - 09/2003
17	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 01/2003
15	Analgesics (Analgesic Drugs)IBA 01/2021 - 09/2003
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2008
8	IronIBA 01/2023 - 11/2002
6	Amyloid (Amyloid Fibrils)IBA 01/2023 - 12/2008
5	Dopamine (Intropin)FDA LinkGeneric 01/2024 - 08/2014
5	Messenger RNA (mRNA)IBA 11/2023 - 08/2002
5	5' Untranslated Regions (5' UTR)IBA 10/2020 - 08/2002
4	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2024 - 01/2014
4	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2022 - 06/2004
4	alpha-SynucleinIBA 10/2020 - 07/2009
3	salicylhydroxamic acid (SHAM)IBA 11/2023 - 01/2022
3	Opiate AlkaloidsIBA 01/2022 - 02/2013
3	Fentanyl (Sublimaze)FDA LinkGeneric 07/2021 - 01/2019
3	RNA (Ribonucleic Acid)IBA 01/2020 - 08/2002
3	Dynorphins (Dynorphin)IBA 01/2019 - 01/2014
3	Chelating AgentsIBA 01/2016 - 11/2002
2	Neuroprotective AgentsIBA 11/2023 - 02/2019
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2022 - 06/2013
2	Narcotic Antagonists (Opioid Antagonists)IBA 01/2021 - 04/2010
2	PlasticsIBA 01/2021 - 01/2019
2	ManganeseIBA 10/2020 - 12/2018
2	Naloxone (Narcan)FDA LinkGeneric 11/2019 - 01/2014
2	metal transporting protein 1 (ferroportin)IBA 02/2019 - 01/2016
2	Opioid Receptors (Opioid Receptor)IBA 01/2019 - 02/2013
2	Ferritins (Ferritin)IBA 01/2016 - 12/2008
2	CytokinesIBA 01/2016 - 12/2008
2	Antidepressive Agents (Antidepressants)IBA 10/2009 - 11/2005
2	MetalsIBA 07/2009 - 12/2008
2	Freund's AdjuvantIBA 10/2005 - 06/2004
2	Peptides (Polypeptides)IBA 11/2002 - 08/2002
1	Minocycline (Cyclops)FDA LinkGeneric 11/2023
1	Drinking WaterIBA 11/2023
1	Flavin-Adenine Dinucleotide (FAD)IBA 01/2023
1	Adenosine Triphosphatases (ATPase)IBA 01/2023
1	butylidenephthalideIBA 09/2022
1	AntiemeticsIBA 05/2022
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2022
1	naltrindoleIBA 01/2022
1	eticloprideIBA 01/2022
1	Heroin (Diamorphine)IBA 07/2021
1	Oxycodone (Oxycontin)FDA LinkGeneric 07/2021
1	Prescription DrugsIBA 07/2021
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 08/2019
1	LigandsIBA 01/2019
1	Amyloidogenic ProteinsIBA 01/2019
1	CannabinoidsIBA 01/2018
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2018
1	RimonabantIBA 01/2018
1	atipamezoleIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2016
1	InterleukinsIBA 01/2016
1	NF-kappa B (NF-kB)IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	OpiumIBA 10/2015

Therapy/Procedure

14	Therapeutics 07/2021 - 08/2002
4	Analgesia 01/2014 - 09/2003
1	Self Medication 01/2024